{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T04:42:54Z","timestamp":1745815374247},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1993,5,1]],"date-time":"1993-05-01T00:00:00Z","timestamp":736214400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[1993,5]]},"DOI":"10.1007\/bf00316472","type":"journal-article","created":{"date-parts":[[2004,10,13]],"date-time":"2004-10-13T00:51:21Z","timestamp":1097628681000},"page":"357-360","source":"Crossref","is-referenced-by-count":4,"title":["Pharmacokinetics and pharmacodynamics of famotidine in patients with reflux oesophagitis"],"prefix":"10.1007","volume":"44","author":[{"given":"U.","family":"Gladziwa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. V.","family":"Dakshinamurty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.El","family":"Desoky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Dreuw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Klotz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/0016-5085(87)90838-9","volume":"92","author":"N Gitlin","year":"1987","unstructured":"Gitlin N, McCullough AJ, Smith JL, Mantell G, Berman R (1987) A multicenter, double-blind, randomized, placebo-controlled comparison of nocturnal and twice-a-day famotidine in the treatment of active duodenal ulcer disease. Gastroenterology 92: 48?53","journal-title":"Gastroenterology"},{"key":"CR2","unstructured":"Reynolds JC (1988) Four independent variables predict duodenal ulcer (DU) healing by famotidine in a relatively unselected patient population: a multivariate analysis of a prospective, multicenter study. Gastroenterology 94: A 374"},{"key":"CR3","unstructured":"Corleto V, Puoti M, Annibale B, Saggioro A, D'Ambra G, Di Paola M, Delle Fave G (1988) Loss of efficacy of famotidine (FMT) in the control of gastric acid secretion in patients with Zollinger-Ellison syndrome (ZES), reversed by omeprazole (OMP). Gastroenterology 94: A 79"},{"key":"CR4","unstructured":"Welage LS, Wing PE, Schentag JJ, Williams JS, Root JK, Berlin RG (1988) An evaluation of intravenous famotidine (F) versus cimetidine (C) therapy in the critically ill. Gastroenterology 94: A 491"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/0016-5085(89)91489-3","volume":"97","author":"AJ McCullough","year":"1989","unstructured":"McCullough AJ, Graham DY, Knuff TE, Lanza FL, Levenson HL, Lyon DT, Munsell WP, Perozza J, Roufail WM, Sinar DR, Smith JL, Berman RS, Root JK, Worley WE, Humphries TJ (1989) Suppression of nocturnal acid secretion with famotidine accelerates gastric ulcer healing. Gastroenterology 97: 860?866","journal-title":"Gastroenterology"},{"key":"CR6","first-page":"548","volume":"9","author":"S Miyake","year":"1987","unstructured":"Miyake S, Yamada M, Iwamoto H (1987) Effect of a new H2-blocker, famotidine, in reflux oesophagitis among severely handicapped children. Clin Ther 9: 548?558","journal-title":"Clin Ther"},{"issue":"134","key":"CR7","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3109\/00365528709090141","volume":"22","author":"T Sekiguchi","year":"1987","unstructured":"Sekiguchi T, Nishioka T, Kogure M, Kusano M, Horikoshi T, Sugiyama T, Kobayashi S (1987) Once-daily administration of famotidine for reflux oesophagitis. Scand J Gastroenterol 22 [Suppl 134]: 51?54","journal-title":"Scand J Gastroenterol"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-2036.1988.tb00692.x","volume":"2","author":"WC Orr","year":"1988","unstructured":"Orr WC, Robinson MG, Humphries TJ, Antonello J, Cagliola A (1988) Dose-response effect of famotidine on patterns of gastro-oesophageal reflux. Aliment Pharmacol Therap 2: 229?235","journal-title":"Aliment Pharmacol Therap"},{"key":"CR9","unstructured":"Festen HPM, Wesdorp ICE, Dekker W (1990) Famotidine 20 mg bid v 40 mg bid in the treatment of erosive\/ulcerative reflux oesophagitis. Gut 31: A 1190"},{"key":"CR10","unstructured":"Savary M, Miller G (1978) The oesophagus handbook and atlas of endoscopy. Gassmann AG, Solothurn: 135?142"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/S0022-5223(19)37879-1","volume":"79","author":"TR DeMeester","year":"1980","unstructured":"DeMeester TR, Wang C-I, Wernly JA, Pellegrini CA, Little AG, Klementschitsch P, Bermudez G, Johnson LF, Skinner DB (1980) Technique, indications, and clinical use of 24 hour oesophageal pH monitoring. J Thorac Cardiovasc Surg 79: 656?670","journal-title":"J Thorac Cardiovasc Surg"},{"key":"CR12","first-page":"458","volume":"25","author":"H Kroemer","year":"1987","unstructured":"Kroemer H, Klotz U (1987) Pharmacokinetics of famotidine in man. Int J Clin Pharmacol Ther Toxicol 25: 458?463","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2165\/00003088-198815040-00001","volume":"15","author":"DR Krishna","year":"1988","unstructured":"Krishna DR, Klotz U (1988) Newer H2-receptor antagonists. Clinical pharmacokinetics and drug interaction potential. Clin Pharmacokinet 15: 205?215","journal-title":"Clin Pharmacokinet"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/BF01535789","volume":"33","author":"GJ Wiener","year":"1988","unstructured":"Wiener GJ, Morgan TM, Copper JB, Wu WC, Castell DO, Sinclair JW, Richter JE (1988) Ambulatory 24-hour oesophageal pH monitoring. Reproducibility and variability of pH parameters. Dig Dis Sci 33: 1127?1133","journal-title":"Dig Dis Sci"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1136\/gut.29.2.157","volume":"29","author":"F Baldi","year":"1988","unstructured":"Baldi F, Ferrarini F, Longanesi A, Angeloni M, Ragazzini M, Miglioli M, Barbara L (1988) Oesophageal function before, during, and after healing of erosive oesophagitis. Gut 29: 157?160","journal-title":"Gut"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"671","DOI":"10.3109\/00365528909093107","volume":"24","author":"S Fiorucci","year":"1989","unstructured":"Fiorucci S, Santucci L, Perrone E, Abbritti F, Morelli A (1989) Gastric and oesophageal acidity during continuous treatment with H2-antagonists in uncomplicated oesophagitis. Scand J Gastroenterol 24: 671?677","journal-title":"Scand J Gastroenterol"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/S0016-5085(86)80017-8","volume":"91","author":"HR Koelz","year":"1986","unstructured":"Koelz HR, Birchler R, Bretholz A, Bron B, Capitaine Y, Delmore G, Fehr HF, Fumagalli I, Gehrig J, Gonvers JJ, Halter F, Hammer B, Kayasseh L, Kobler E, Miller G, M\u00fcnst G, Pelloni S, Realini S, Schmid P, Voirol M, Blum AL (1986) Healing and relapse of reflux oesophagitis during treatment with ranitidine. Gastroenterology 91: 1198?1205","journal-title":"Gastroenterology"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1136\/gut.31.5.509","volume":"31","author":"TCB Dehn","year":"1990","unstructured":"Dehn TCB, Shepherd HA, Colin-Jones D, Kettlewell MGW, Carroll NJH (1990) Double blind comparison of omeprazole (40 mg od) versus cimetidine (400 mg qd) in the treatment of symptomatic erosive reflux oesophagitis, assessed endoscopically, histologically and by 24 h pH monitoring. Gut 31: 509?513","journal-title":"Gut"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1136\/gut.31.7.745","volume":"31","author":"KD Bardhan","year":"1990","unstructured":"Bardhan KD, Morris P, Thompson M, Dhande DS, Hinchliffe RFC, Jones RB, Daly MJ, Carroll NJH (1990) Omeprazole in the treatment of erosive oesophagitis refractory to high dose cimetidine and ranitidine. Gut 31: 745?749","journal-title":"Gut"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1136\/gut.31.9.968","volume":"31","author":"CM Bate","year":"1990","unstructured":"Bate CM, Keeling PWN, O'Morain C, Wilkonson SP, Foster DN, Mountford RA, Temperley JM, Harvey RF, Thompson DG, Davis M, Forgacs IC, Bassett KS, Richardson PDI (1990) Comparison of omeprazole and cimetidine in reflux oesophagitis: symptomatic, endoscopic, and histological evaluations. Gut 31: 968?972","journal-title":"Gut"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0140-6736(87)93005-4","volume":"II","author":"P Zeitoun","year":"1987","unstructured":"Zeitoun P, Desjars de Keranrou\u00e9 N, Isal JP (1987) Omeprazole versus ranitidine in erosive oesophagitis. Lancet II: 621?622","journal-title":"Lancet"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0140-6736(87)91726-0","volume":"I","author":"EC Klinkenberg-Knol","year":"1987","unstructured":"Klinkenberg-Knol EC, Jansen JMBJ, Festen HPM, Meuwissen SGM, Lamers CBHW (1987) Double-blind multicentre comparison of omeprazole and ranitidine in the treatment of reflux oesophagitis. Lancet I: 349?351","journal-title":"Lancet"},{"key":"CR23","unstructured":"Bate CM, Crowe J, Dickinson RJ, Green JRB, Smith PM, Dronfield MW, MacFarland RJ, Bassett KS, Richardson PDI (1990) Omeprazole 20 mg om v ranitidine 150 mg bd in reflux oesophagitis; omeprazole 40 mg om ? a strategy for treatment failures. Gut 31: A 1190"},{"key":"CR24","unstructured":"Bianchi Porro G, Pace F, Sangaletti O, Peracchia A, Bonavina L, Vigneri S, Muratore F (1990) Omeprazole or ranitidine at standard or doubled doses in the treatment of patients with refractory reflux oesophagitis. Gut 31: A 1189"},{"issue":"166","key":"CR25","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3109\/00365528909091250","volume":"24","author":"P Zeitoun","year":"1989","unstructured":"Zeitoun P (1989) Comparison of omeprazole with ranitidine in the treatment of reflux oesophagitis. Scand J Gastroenterol 24 [Suppl 166]: 83?87","journal-title":"Scand J Gastroenterol"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00316472.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00316472\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00316472","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T10:08:23Z","timestamp":1585908503000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00316472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,5]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1993,5]]}},"alternative-id":["BF00316472"],"URL":"https:\/\/doi.org\/10.1007\/bf00316472","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,5]]}}}